Open Government Portal
This section of the guidance outlines the additional requirements for good clinical practices, qualified investigators, and labelling.
This section of the guidance outlines the application processes and guidelines under the Regulations.
This section of the guidance outlines requirements for the licence holder after authorization of the clinical trials.
The purpose of this notice is to advise stakeholders that Health Canada is proposing to: maintain the flexibilities and regulatory …
The purpose of this Notice of Amendment is to notify about the addition of casirivimab and imdevimab to the Prescription …
The purpose of this Notice of Amendment is to notify about the addition of sotrovimab to the Prescription Drug List …
COVID-19 and other drug product announcements until July 2023.
General COVID-19 flexibilities for all disinfectant application/submission pathways.
Steps to select the applicable fee category, the proper application stream and the pathways used to seek an authorization for …
This document provides information on the application process and application contents for a disinfectant drug product regulated under the Food …